VIR BIOTECHNOLOGY INC (VIR) Stock Income Statement
NASDAQ:VIR - Nasdaq - US92764N1028 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.86M | 74.20M | 86.18M | 1.62B | 1.10B | |||
| Minority Interest Expense | N/A | 0.00 | 56.00K | N/A | N/A | |||
| Cost Of Goods | 786.00K | 845.00K | 2.77M | 146.30M | 65.90M | |||
| Gross Profit | 20.07M | 73.36M | 83.42M | 1.47B | 1.03B | |||
| Operating Expenses | 631.67M | 625.53M | 767.72M | 636.40M | 608.80M | |||
| Research and Development | 525.02M | 506.20M | 589.17M | 474.10M | 447.50M | |||
| Selling, General, and Administrative Expenses | 106.65M | 119.03M | 178.05M | 161.80M | 160.80M | |||
| Operating Income | -611.60M | -552.17M | -684.30M | 833.10M | 420.80M | |||
| Interest Income/Expense | 69.58M | 66.28M | 65.10M | -83.00M | 138.50M | |||
| Other Income/Expense | -2.01M | -2.22M | -8.99M | 4.30M | -9.40M | |||
| Non Recurring Items | -35.03M | -34.99M | N/A | N/A | N/A | |||
| Income Before Taxes | -579.05M | -523.11M | -628.19M | 754.30M | 549.80M | |||
| Income Tax | -1.41M | -1.15M | -13.08M | 238.40M | 21.20M | |||
| Net Income | -577.65M | -521.96M | -615.06M | 515.80M | 528.60M | |||
| EBITDA | -598.69M | -537.61M | -664.85M | 839.90M | 426.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.22 | -3.83 | -4.59 | 3.83 | 3.96 | |||
| Non GAAP EPS | -4.22 | -3.82 | -4.59 | 3.81 | 3.88 | |||
| Statistics | ||||||||
| Gross Profit Margin | 96.23% | 98.86% | 96.79% | 90.95% | 93.99% | |||
| Profit Margin | -2769.04% | -703.40% | -713.69% | 31.92% | 48.26% | |||
| Operating Profit Margin | -2931.78% | -744.11% | -794.04% | 51.56% | 38.42% | |||
All data in USD